Nothing Special   »   [go: up one dir, main page]

Zhong et al., 2014 - Google Patents

Discovery of functionalized bisimidazoles bearing cyclic aliphatic-phenyl motifs as HCV NS5A inhibitors

Zhong et al., 2014

Document ID
10239553268791020989
Author
Zhong M
Peng E
Huang N
Huang Q
Huq A
Lau M
Colonno R
Li L
Publication year
Publication venue
Bioorganic & Medicinal Chemistry Letters

External Links

Snippet

This Letter describes the discovery of a number of functionalized bisimidazoles bearing a cyclohexylphenyl, piperidylphenyl, or bicyclo [2, 2, 2] octylphenyl motif as HCV NS5A inhibitors. Compounds 2c, 4b and 6 have demonstrated low single-digit nM potency in gt-1a …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin

Similar Documents

Publication Publication Date Title
Zhong et al. Discovery of functionalized bisimidazoles bearing cyclic aliphatic-phenyl motifs as HCV NS5A inhibitors
Lin et al. Curing a viral infection by targeting the host: the example of cyclophilin inhibitors
ES2680550T3 (en) Hepatitis C virus inhibitor combinations
Hwang et al. Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system
Rai et al. New opportunities in anti-hepatitis C virus drug discovery: targeting NS4B
Schmitz et al. NS5A-from obscurity to new target for HCV therapy
Narjes et al. Discovery of (7 R)-14-cyclohexyl-7-{[2-(dimethylamino) ethyl](methyl) amino}-7, 8-dihydro-6 H-indolo [1, 2-e][1, 5] benzoxazocine-11-carboxylic acid (MK-3281), a potent and orally bioavailable finger-loop inhibitor of the hepatitis C virus NS5B polymerase
Huang et al. Recent development of therapeutics for chronic HCV infection
CA2369970A1 (en) Hepatitis c inhibitor tri-peptides
Zhong et al. Discovery of novel potent HCV NS5B polymerase non-nucleoside inhibitors bearing a fused benzofuran scaffold
TW200838529A (en) Macrocyclic inhibitors of hepatitis C virus
Chen et al. C-6 aryl substituted 4-quinolone-3-carboxylic acids as inhibitors of hepatitis C virus
Pawlotsky What are the pros and cons of the use of host-targeted agents against hepatitis C?
Zhong et al. Discovery of ravidasvir (PPI-668) as a potent pan-genotypic HCV NS5A inhibitor
Zoidis et al. Novel indole–flutimide heterocycles with activity against influenza PA endonuclease and hepatitis C virus
Zhang et al. Discovery and evolution of aloperine derivatives as a new family of HCV inhibitors with novel mechanism
Venkatraman et al. Discovery and structure− activity relationship of P1− P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease
Dwyer et al. Matched and mixed cap derivatives in the tetracyclic indole class of HCV NS5A inhibitors
Ruebsam et al. Pyrrolo [1, 2-b] pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
Zhong et al. Potent bisimidazole-based HCV NS5A inhibitors bearing annulated tricyclic motifs
Chen et al. The journey to the discovery of boceprevir: an NS3–NS4 HCV protease inhibitor for the treatment of chronic hepatitis C
Avolio et al. Inhibitors of hepatitis C virus NS3/4A: α-Ketoamide based macrocyclic inhibitors
US20110064694A1 (en) Anti-hepatitis c activity of meso-tetrakis-porphyrin analogues
Zhong et al. Structure–activity relationship studies on quinoxalin-2 (1 H)-one derivatives containing thiazol-2-amine against hepatitis C virus leading to the discovery of BH6870
Kang et al. Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors